Cardinal Health international leader emphasises enhanced customer value through new go-to-market model

MedTech & Diagnostics News: In an exclusive interview with Health Industry Hub, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, delved into his two-decade-long journey in the healthcare, medical devices, and fast-moving consumer goods (FMCG) sectors, and the key milestones that have shaped his journey within the Cardinal Health.

The conversation then turned to the critical challenges and complexities that the healthcare ecosystem faces today. In his role, Mr Sahlieh underscored the significance of customer centricity, both in terms of patients and healthcare professionals (HCPs), in addressing these challenges. Reimagining healthcare is a paramount goal for the industry, and the discussion expanded to the role of medtech companies like Cardinal Health in forging a path toward equitable access to healthcare services.

Over the last year, Cardinal Health has embarked on a transformative journey to enhance its operations guided by the principles of “focus and simplicity.” The interview delved into how this transformation is aligning with the evolving needs of the business and healthcare providers, ensuring streamlined operations and enhanced service delivery.

Looking ahead, Mr Sahlieh explored the top trends shaping the future of the medtech sector and how Cardinal Health is strategically aligning its business to thrive in this dynamic ecosystem. He offered valuable insights into the company’s forward-looking strategies and its commitment to staying at the forefront of the medtech industry.

In reimagining healthcare, Health Industry Hub^TM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.